James M. Mock
Known title: Chief Financial OfficerCIK: 0001736359
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Revvity Announces Earnings Call, Analysts Upgrade Rating. Revvity has announced that it will conduct an earnings call on November 3, 2026. Analysts have upgraded the stock’s rating, citing stronger fundamentals and a positive outlook. Today’s trading saw unusual volume and the price is near its support level of $110.97 with an RSI of 68.9, indicating a moderately overbought condition.
Transaction History
| MRNA | ▲ Buy | Option Exercise | 1,454 | — | 10/5/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 704 | $134K | 10/5/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 19,836 | $614K | 9/10/2026 | View on chart |
| MRNA | ▼ Sell | Open Market | 19,836 | $2.7M | 9/10/2026 | View on chart |
| MRNA | ▼ Sell | Open Market | 15,000 | $2.0M | 9/10/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 11,797 | — | 9/4/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 5,704 | $849K | 9/4/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 2,475 | — | 9/1/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 1,197 | $168K | 9/1/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 8/28/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 160 | $23K | 8/28/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 774 | — | 8/27/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 375 | $56K | 8/27/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,452 | — | 7/2/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 703 | $51K | 7/2/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 11,798 | — | 6/5/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 5,705 | $294K | 6/5/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 2,475 | — | 6/1/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 1,197 | $56K | 6/1/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 328 | — | 5/28/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 159 | $8K | 5/28/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 773 | — | 5/27/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 374 | $18K | 5/27/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 4/2/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 703 | $35K | 4/2/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 11,797 | — | 3/5/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 5,704 | $330K | 3/5/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 2/27/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 160 | $8K | 2/27/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 774 | — | 2/27/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 375 | $19K | 2/27/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 9,901 | — | 2/27/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 4,788 | $248K | 2/27/2026 | View on chart |
| MRNA | ▲ Buy | Grant | 2,630 | $0 | 2/11/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 1,278 | $54K | 2/11/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,452 | — | 1/5/2026 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 780 | $24K | 1/5/2026 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 47,190 | — | 12/5/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 22,817 | $582K | 12/5/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 11/28/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 160 | $4K | 11/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 773 | — | 11/26/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 374 | $9K | 11/26/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 10/3/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 703 | $20K | 10/3/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 160 | $4K | 8/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 8/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 774 | — | 8/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 375 | $9K | 8/27/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 7/3/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 703 | $21K | 7/3/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 328 | — | 5/28/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 159 | $4K | 5/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 773 | — | 5/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 374 | $10K | 5/27/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,452 | — | 4/4/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 703 | $18K | 4/4/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 160 | $5K | 2/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 2/28/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 2/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 642 | $22K | 2/27/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 3,094 | — | 2/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 1,496 | $50K | 2/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 642 | $22K | 2/27/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 2/27/2025 | View on chart |
| MRNA | ▼ Sell | Tax Withholding | 780 | $33K | 1/3/2025 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 1/3/2025 | View on chart |
| MRNA | ▼ Sell | Open Market | 1,420 | $61K | 11/29/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 11/27/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 11/27/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 11/27/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 715 | $43K | 10/7/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 10/4/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 162 | $13K | 8/29/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 1,321 | $105K | 8/28/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 329 | — | 8/28/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 8/27/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 8/27/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 689 | $81K | 7/8/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,452 | — | 7/5/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 691 | $97K | 6/3/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 5/31/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 183 | $26K | 5/29/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 328 | — | 5/28/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 648 | $105K | 5/28/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,326 | — | 5/24/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 705 | $72K | 4/8/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,453 | — | 4/5/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 647 | $61K | 2/29/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,315 | — | 2/28/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 772 | $85K | 1/8/2024 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 1,452 | — | 1/5/2024 | View on chart |
| MRNA | ▼ Sell | Open Market | 2,858 | $293K | 10/6/2023 | View on chart |
| MRNA | ▲ Buy | Option Exercise | 5,810 | — | 10/5/2023 | View on chart |
| RVTY | ▼ Sell | Open Market | 2,072 | $300K | 6/24/2022 | View on chart |
| RVTY | ▼ Sell | Open Market | 2,290 | $334K | 6/24/2022 | View on chart |
| RVTY | ▼ Sell | Open Market | 663 | $97K | 6/24/2022 | View on chart |
| RVTY | ▲ Buy | Grant | 13,054 | $0 | 2/7/2022 | View on chart |
| RVTY | ▼ Sell | Tax Withholding | 4,998 | $914K | 2/7/2022 | View on chart |
| RVTY | ▼ Sell | Tax Withholding | 1,448 | $265K | 2/7/2022 | View on chart |
| RVTY | ▲ Buy | Grant | 2,750 | $0 | 2/4/2022 | View on chart |
| RVTY | ▼ Sell | Open Market | 1,300 | $238K | 9/20/2021 | View on chart |
| RVTY | ▼ Sell | Open Market | 1,803 | $332K | 9/20/2021 | View on chart |
| RVTY | ▼ Sell | Open Market | 1,377 | $255K | 9/20/2021 | View on chart |
| RVTY | ▼ Sell | Open Market | 400 | $74K | 9/20/2021 | View on chart |
| RVTY | ▼ Sell | Open Market | 1,100 | $206K | 9/20/2021 | View on chart |
| RVTY | ▼ Sell | Open Market | 100 | $19K | 9/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Moderna faces stock dip amid cancer vaccine news and cash position
Recent articles note that Moderna holds a large cash reserve while advancing a deep cancer pipeline. A Phase 3 trial of its cancer vaccine reported positive results, which could broaden the company's product base. At the same time, the stock has fallen sharply, reflecting broader weakness in biotech and a pause in the recent rally. The decline occurs despite the cash strength and analyst price targets that remain well above current levels.
Moderna faces stock dip amid cancer vaccine news and cash position. Recent articles note that Moderna holds a large cash reserve while advancing a deep cancer pipeline. A Phase 3 trial of its cancer vaccine reported positive results, which could broaden the company's product base. At the same time, the stock has fallen sharply, reflecting broader weakness in biotech and a pause in the recent rally. The decline occurs despite the cash strength and analyst price targets that remain well above current levels.